Vantage logo

Medtech VC and the billion-dollar era

The first one-shot billion-dollar venture investment round in the medical technology sector has gone to Verily as computing bleeds into medicine.

Vantage logo

Death of a unicorn

Moderna’s upsized IPO is the biggest-ever for a pre-commercial biotech. But its share price has fallen in early trade on its first day.

Vantage logo

Moderna picks its moment

The buttoned-up biotech, recently valued at $7bn, has finally unveiled plans to go public. But investor appetite for new issues has taken a knock. Does Moderna’s move…